Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.
about
An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study.Creatine: a miserable life without it.
P2860
Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Creatine target engagement wit ...... ith SSRI-resistant depression.
@en
Creatine target engagement wit ...... ith SSRI-resistant depression.
@nl
type
label
Creatine target engagement wit ...... ith SSRI-resistant depression.
@en
Creatine target engagement wit ...... ith SSRI-resistant depression.
@nl
prefLabel
Creatine target engagement wit ...... ith SSRI-resistant depression.
@en
Creatine target engagement wit ...... ith SSRI-resistant depression.
@nl
P2093
P2860
P1433
P1476
Creatine target engagement wit ...... ith SSRI-resistant depression.
@en
P2093
Douglas G Kondo
Lauren N Forrest
Rebekah S Huber
Tracy L Hellem
Xianfeng Shi
Young-Hoon Sung
P2860
P2888
P304
P356
10.1007/S00726-016-2194-3
P577
2016-02-23T00:00:00Z